Table of Contents May 06, 2024; Volume Issue Supplement 1
An, Shuxian
- You have accessPathway to Approval of Innovative Radiopharmaceuticals in ChinaShuxian An, Lu Wang, Fang Xie, Dawei Jiang, Gang Huang, Jianjun Liu, Xiaowei Ma and Weijun WeiJournal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 72S-76S; DOI: https://doi.org/10.2967/jnumed.123.267127
Cai, Weibo
- You have accessAdvancing Global Nuclear Medicine: The Role and Future Contributions of ChinaHaojun Chen, Kuangyu Shi, Weibo Cai, Sijin Li and Jing WangJournal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 1S-S3; DOI: https://doi.org/10.2967/jnumed.124.267918
Chen, Haojun
- You have accessFibroblast Activation Protein Inhibitor Tracers and Their Preclinical, Translational, and Clinical Status in ChinaLiang Zhao, Fei Kang, Yizhen Pang, Jianyang Fang, Long Sun, Hua Wu, XiaoLi Lan, Jing Wang and Haojun ChenJournal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 4S-11S; DOI: https://doi.org/10.2967/jnumed.123.266983
- You have accessAdvancing Global Nuclear Medicine: The Role and Future Contributions of ChinaHaojun Chen, Kuangyu Shi, Weibo Cai, Sijin Li and Jing WangJournal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 1S-S3; DOI: https://doi.org/10.2967/jnumed.124.267918
Chen, Wanqi
- You have accessAdvantages and Challenges of Total-Body PET/CT at a Tertiary Cancer Center: Insights from Sun Yat-sen University Cancer CenterWanqi Chen, Yinghe Li, Zhijian Li, Yongluo Jiang, Yingpu Cui, Jiling Zeng, Yiwen Mo, Si Tang, Shatong Li, Lei Liu, Yumo Zhao, Yingying Hu and Wei FanJournal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 54S-63S; DOI: https://doi.org/10.2967/jnumed.123.266948
Chen, Xuejiao
- You have accessRecent Advances in Radiotracers Targeting Novel Cancer-Specific Biomarkers in China: A Brief OverviewJingming Zhang, Fei Kang, Xiao Wang, Xuejiao Chen, Xing Yang, Zhi Yang and Jing WangJournal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 38S-45S; DOI: https://doi.org/10.2967/jnumed.123.266314
Chen, Xueqi
- You have accessTranslational PET Imaging of Nectin-4 Expression in Multiple Different Cancers with 68Ga-N188Jianhua Zhang, Xiaojiang Duan, Xueqi Chen, Zhuochen Zhang, Hongwei Sun, Jiayin Shou, Guangyu Zhao, Jianxin Wang, Yongsu Ma, Yinmo Yang, Xiaodong Tian, Qi Shen, Wei Yu, Zhisong He, Yan Fan and Xing YangJournal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 12S-18S; DOI: https://doi.org/10.2967/jnumed.123.266830
Chen, Yue
- You have accessLandscape of Nuclear Medicine in China and Its Progress on TheranosticsWeidong Yang, Fei Kang, Yue Chen, Zhaohui Zhu, Feng Wang, Chunxia Qin, Jin Du, Xiaoli Lan and Jing WangJournal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 29S-37S; DOI: https://doi.org/10.2967/jnumed.123.266968
Cheng, Zhaoping
- You have accessClinical Implementation of Total-Body PET in ChinaYaping Wu, Tao Sun, Yee Ling Ng, Jianjun Liu, Xiaohua Zhu, Zhaoping Cheng, Baixuan Xu, Nan Meng, Yun Zhou and Meiyun WangJournal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 64S-71S; DOI: https://doi.org/10.2967/jnumed.123.266977
Cui, Yingpu
- You have accessAdvantages and Challenges of Total-Body PET/CT at a Tertiary Cancer Center: Insights from Sun Yat-sen University Cancer CenterWanqi Chen, Yinghe Li, Zhijian Li, Yongluo Jiang, Yingpu Cui, Jiling Zeng, Yiwen Mo, Si Tang, Shatong Li, Lei Liu, Yumo Zhao, Yingying Hu and Wei FanJournal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 54S-63S; DOI: https://doi.org/10.2967/jnumed.123.266948
Du, Jin
- You have accessLandscape of Nuclear Medicine in China and Its Progress on TheranosticsWeidong Yang, Fei Kang, Yue Chen, Zhaohui Zhu, Feng Wang, Chunxia Qin, Jin Du, Xiaoli Lan and Jing WangJournal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 29S-37S; DOI: https://doi.org/10.2967/jnumed.123.266968